RE:RE:RE:Analysts and their positionsYouLoser:
You shouldn't send people to a site and cherry pick the only two negative comments. Here is what I found on going to WebMD on Donnatal.
Effectiveness - 4.33/5.00
Ease of use - 4.58/5.00
Satisfaction - 4.22/5.00
Also vast majority of comments and ratings are positive. See for yourself:
[url=https://https://www.webmd.com/drugs/drugreview-6767-Donnatal+oral.aspx?drugid=6767&drugname=Donnatal+oral&conditionFilter=-500]https://www.webmd.com/drugs/drugreview-6767-Donnatal+oral.aspx?drugid=6767&drugname=Donnatal+oral&conditionFilter=-500[/url]
Now let's take a look at another site with 18 reviews:
Average rating 9.5, with 16 reviews for treatment of IBS 9.6.
All comments overwhelmingly positive. See for yourself:
[url=https://https://www.drugs.com/comments/atropine-hyoscyamine-phenobarbital-scopolamine/donnatal.html]https://www.drugs.com/comments/atropine-hyoscyamine-phenobarbital-scopolamine/donnatal.html[/url]
Donnatal has been in use for 40 years. This is not a new drug, and it's effectiveness is proven. If it works, and it does work, people will use it, doctors will prescribe it, and CXR will make money off it. Not only that, it costs a fraction of what its competitors cost!
Regards,
YouWin
YouLose wrote: I have to agree with this completely. And I would add, for a company like CXR, it makes sense to talk to their customers as well. I did my own DD and checked out reviews for Donnatal on WebMD and invite others to do the same. Clearly none of the analysts touting the company adding 100 sales agents for this bothered to investigate the risks. Here are a couple of reviews I read:
"
Comment: took this for 4 years in the mid to late 90s dr. never told me it was a barbituate he kept upping the dose i finnally told him i dont want to take it anymore it wasnt working he told me i needed to go to a rehab to detox off of them or i could sezuire up and die it cost me 4000 dollars out of my own pocket and this guy never gave me an ultrasound 3 months later i was rushed to the er an ulersound was taken and i was loaded with gallstones i was only 38 the surgeon said i had them for years the doctor then left the practice wouldnt reimburse me for detox which was horrible that stuff is so habit forming and dangerous try getting off it,it sucks.and have your dr. give you an ultrasound to see what the real problem is." And
"
Comment: I was prescribed this drug after Zelnorm was pulled by the FDA. I have taken Donnatal for 3 months. While it helps control the painful spasms of IBS, the side effects are many and I am going to quit taking it. My side effects are: Dizzyness, feeling faint, blood pressure drop upon standing, extreme tiredness, trouble concentrating at work, memory problems (can't remember the right word, can't recall names), joint aches, muscle weakness. " Certainly doesn't appear to be the wonder drug that we were led to believe by certain members on this board. Sure they can add 100 sales agents for this in the states, but if doctors don't trust it, if patients don't ask for it, and if noone prescribes it, it wouldn't matter if you have 10,000 more sales agents.
notwrong wrote: I have no idea what position you take, but I would say that your suggestion is an excellent one. In the past, I also proposed such a suggestion on another bull board. I have no doubt about the computational abilities of professional analysts, but the problem is with the accuracy and source of information they can gather based on which they do their computations. Through the flawed convention of completely relying on text information sources and released company quarterly reports, they make their analysis through no fault of their own. What needs to change is for the professional analyst community to adopt a hands on approach by actually visiting the companies on site and inspect their operations and talk to the employees and executives. Take the example of Sinoforest or Bre-X, which later proved to be complete frauds, but before they were exposed, analysts gave high ratings to these companies. If they had visited these companies on site and inspected their operations to actually check them out, they would not have been fooled by the text source information and the quarterly reports released by these companies.
I am not putting any blame on the analysts. Rather, there is a need for the professional analyst community to correct the existing flaws or pitfalls of their current information and data gathering methodologies by reinforcing or adding the information verification and validation process.
Just an opinion.